Roche’s Actemra May Curb Deaths in Critical Covid Patients

Roche Holding AG’s Actemra may help critically ill patients survive Covid-19, according to researchers who used a novel approach to show those who quickly got the anti-inflammatory medication were 30% less likely to die.